Skip to main navigation Skip to search Skip to main content
William Fraser

View Scopus Profile

William Fraser

Dr

 https://orcid.org/0000-0001-6588-0166

Accepting PhD Students

PhD projects

Small molecule and oligonucleotide approaches against microbial resistance mechanisms

Personal profile

Membership of Professional Bodies

Fellow of the Royal Society of Chemistry (FRSC)

Fellow of the Higher Education Academy (FHEA)

Chartered Chemist (CChem)

Chartered Scientist (CSi)

Teaching Activity

Aston Pharmacy School MPharm course:

Chemical aspects of pharmacy

Theme lead for Personalisation of Pharmaceuticals (POP)

PH2519 depth assessment lead for Drugs to Market (DTM)

PH3619 depth assessment lead for Inflammation and Immunity (IAI).

Various MSc courses:

Module leader for PHM202 - Drug Discovery

Module leader for PHM205 Principles of Product Analysis and Validation

Education/Academic qualification

PhD, The Design Synthesis and Testing of Inhibitors of Dihydroorotate Dehydrogenase, University of Strathclyde

1 Oct 1986 → 1 Sept 1989

Award Date: 6 Nov 1989

BSc, First Class Honours in Chemistry, University of Strathclyde

1 Oct 1982 → 30 Jun 1986

Award Date: 31 Jul 1986

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where William Fraser is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further
  • 12 Article
  • 5 Chapter
  • 2 Chapter (peer-reviewed)
  • 1 Conference abstract

  • Methyl 2-deoxy-3,5-di-O-p-toluoyl-α-d-ribofuranoside: isolation, crystal structure and conformation

    Dodd, E., Coles, S. J. & Fraser, W., 1 Apr 2026, In: Carbohydrate Research. 562, 4 p., 109831.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    3 Downloads (Pure)

  • DNA Triplex-Formation by a Covalent Conjugate of the Anticancer Drug Temozolomide

    Fraser, W. & Walsh, A. J., 22 Jul 2025, In: DNA. 5, 3, 12 p., 36.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    7 Downloads (Pure)

  • 1,2,3-Oxadiazoles

    Fraser, W., 2022, Comprehensive Heterocyclic Chemistry IV. Elsevier, p. 122-146 25 p.

    Research output: Chapter in Book/Published conference output › Chapter

  • Oxatriazoles

    Fraser, W., 2022, Comprehensive Heterocyclic Chemistry IV. Black, D., Cossy, J. & Stevens, C. (eds.). 1 ed. Elsevier, p. 233-244 12 p.

    Research output: Chapter in Book/Published conference output › Chapter

  • 1,2,3-Oxadiazoles

    Fraser, W., 2 Dec 2021, Comprehensive Heterocyclic Chemistry IV. Black, D., Cossy, J. & Stevens, C. (eds.). 1 ed. Elsevier

    Research output: Chapter in Book/Published conference output › Chapter (peer-reviewed) › peer-review

View all 20 research outputs
  • 2 Publication peer-review
  • 1 Editorial activity